- 1、本文档共9页,可阅读全部内容。
- 2、有哪些信誉好的足球投注网站(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。
- 3、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载。
- 4、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
查看更多
Toward a Psitive and Comprehensive Diagnosis of IBS
Toward a Positive and Comprehensive Diagnosis of Irritable Bowel Syndrome
Yehuda Ringel, MD, and Douglas A. Drossman, MD, University of North Carolina, Chapel Hill
Medscape General Medicine.?2000;2(4)?
Irritable bowel syndrome (IBS) is one of the most frequently diagnosed disorders in general population and medical settings. It accounts for an estimated 28% of patients seen in gastroenterology practice and up to 12% of patients seen in primary care practice. IBS affects about 10% to 20% of adolescents and adults (14% to 24% female, 5% to 19% male) in Western countries. The disorder can substantially impair the patients quality of life and increase annual healthcare costs; it poses a considerable socioeconomic burden on the healthcare system overall.[1-3]?The high prevalence and significant sequelae of IBS have led to increased interest in this disorder among clinicians, clinical investigators, basic scientists, physiologists, and mental health professionals.
Indeed, over the last 2 decades there has been a 10-fold increase in citations on IBS.[4]?The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) and various gastroenterologic societies have increased the exposure of IBS through educational and research programs. Most recently, the pharmaceutical industry has begun international marketing campaigns related to new enteric receptor agents. Nevertheless, the etiology and pathogenesis of IBS still are not completely characterized, and no unique morphologic, physiologic, or pathologic pattern that can serve as a marker for the disorder has been identified. Such circumstances where an illness exists without a defined disease create certain diagnostic dilemmas for the clinician: (1) Is IBS a genuine disorder, with clearly definable determinants? (2) How can the diagnosis be made in the absence of a biological marker? (3) How confident can the clinician be in making the diagnosis?
During the last 20 years, significant changes have occurred in how we
文档评论(0)